June Zazenkai 2022

A 1-day meditation retreat
(available via Zoom with some limited on-site participation available)

Friday, June 17 (eve.) – Saturday, June 18

Led by Dharma-Holder Rev. Jonathan Kaigen Levy


Zazenkai is a daylong retreat devoted to samadhi practice, with Great Silence observed throughout the day. This Zazenkai, offered both in-person at ZCLA and via Zoom, is an opportunity to intensify and deepen your practice through the experience of periods of uninterrupted meditation (zazen), walking meditation (kinhin), a dharma talk, service, face-to-face meetings with Dharma-Holder Rev. Jonathan Kaigen Levy, as well as time for mindful work practice (samu) and meals. Zoom participants will have time to eat, walk and do their own samu at home, then link back into the sesshin schedule. Open to everyone, newcomers are especially welcomed to attend*.

Click here to view the schedule.

Deadline to register: Wednesday, June 8.


In-person participation is limited. Please register early to guarantee a seat in the Zendo.

(Housing fees must be paid separately. If you have concerns about payments or any other questions, please contact programsteward@zcla.org)


Please note: All participants must be fully vaccinated and be prepared to show proof of vaccination upon arrival. Stay-over guests are asked to bring along two at-home Covid tests and provide an emergency contact number.


*Non-members and new members: Attending an in-person “Introduction to Zen Meditation Class” is a prerequisite for attending all onsite activities.



Check off your days:

Enter any additional notes regarding your retreat registration:

Reverend Jonathan Kaigen Levy is a ZCLA priest, Dharma-Holder and transmitted Preceptor. For many years he was Co-Steward of the ZCLA Tenzo Circle, which oversaw the preparation of Sangha meals, he was Co-Steward of the Introduction to Meditation classes, the 2018-2019 Shuso (Head Trainee), and is one of the leaders of “Explore Your Practice” meetings on Wednesday nights. A retired film editor, he now councils men diagnosed with prostate cancer.